California State Teachers Retirement System (CalSTRS)’s DiaMedica Therapeutics DMAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.4K Sell
1,837
-254
-12% -$2.01K ﹤0.01% 2596
2025
Q4
$16.6K Buy
2,091
+442
+27% +$3.31K ﹤0.01% 2592
2025
Q3
$11.3K Buy
1,649
+1
+0.1% +$5 ﹤0.01% 2784
2025
Q2
$6.43K Buy
+1,648
New +$6.43K ﹤0.01% 2868

Other funds holding DMAC

California State Teachers Retirement System (CalSTRS)'s DMAC Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its DiaMedica Therapeutics (DMAC) stake by 12% in Q1 2026, selling an estimated $2.01K and leaving 1,837 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

California State Teachers Retirement System (CalSTRS) first reported a position in DMAC in Q2 2025 and has held it in 4 quarters since. The position peaked at $16.6K in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 1,837 shares of DiaMedica Therapeutics worth $12.4K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 254 DiaMedica Therapeutics shares in Q1 2026, an estimated $2.01K.
  • DiaMedica Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2596 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in DiaMedica Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s DiaMedica Therapeutics position peaked at $16.6K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.